109 results
424B5
GOVX
Geovax Labs Inc
21 May 24
Prospectus supplement for primary offering
12:32pm
exceed policy limits, divert management’s attention, and adversely affect our reputation and demand for our products.
Reimbursement decisions by third
POS AM
GOVX
Geovax Labs Inc
1 Mar 24
Prospectus update (post-effective amendment)
4:04pm
liability claims, regardless of their merits, could exceed policy limits, divert management’s attention, and adversely affect our reputation
POS AM
GOVX
Geovax Labs Inc
1 Mar 24
Prospectus update (post-effective amendment)
4:04pm
, regardless of their merits, could exceed policy limits, divert management’s attention, and adversely affect our reputation and demand for our products
POS AM
GOVX
Geovax Labs Inc
1 Mar 24
Prospectus update (post-effective amendment)
4:03pm
reputation and demand for our products.
Reimbursement decisions by third-party payors may have an adverse effect on pricing and market acceptance
POS AM
5xz17vbdcv17d8opes
1 Mar 24
Prospectus update (post-effective amendment)
4:03pm
424B3
bt8loumjph5n i6otbz
12 Jan 24
Prospectus supplement
4:00pm
S-8
EX-99.1
09q8 8wco2u7tarh2
22 Aug 23
Registration of securities for employees
4:06pm
S-8
EX-99.2
2hdbhpu5 9o
22 Aug 23
Registration of securities for employees
4:06pm
424B5
0uflmmdq7k
18 Jul 23
Prospectus supplement for primary offering
4:13pm
8-K
EX-10.1
rj1ljn1v036 301
8 Dec 22
GeoVax Appoints Jayne Morgan, M.D., to its Board of Directors
3:53pm
424B3
3iojs
27 Jun 22
Prospectus supplement
9:13am
424B5
tvxk5 34jb14t6l2s8a
27 May 22
Prospectus supplement for primary offering
8:49am
POS AM
yeoubcl hkn60hr
9 Mar 22
Prospectus update (post-effective amendment)
8:42pm